Animal studies have shown concerns like reduced fetal growth, developmental abnormalities, and pregnancy loss at doses similar to those used in humans
Take the clinical trials for Wegovy as an example: participants with type 2 diabetes lost an average of 3.9% of their body weight within three months, compared to 6.3% in those without diabetes
I've seen studies showing as many as 80% of people will regain the majority of their weight when coming off of calorie restriction
Unfortunately, it is impossible to say in advance whether and how quickly this will work for you as a patient
Effects on lipid profile T2DM patients have usually atherogenic dyslipidemia, depicted by high triglycerides and low-density lipoprotein cholesterol (LDL-C) levels, accompanied by low levels of high-density lipoprotein cholesterol (HDL-C)
The challenge isnt creating more GLP-1its understanding how to activate the cells that produce it and protect the hormone from rapid degradation